Eloxx Pharmaceuticals
$2.959876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.
$2.95
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
-$0.23 (-7.23%) Today
$0.00 (0.00%) As of 12:00 AM UTC after-hours
Why Robinhood?
You can buy or sell ELOX and other stocks, options, and ETFs commission-free!
About ELOX
Eloxx Pharmaceuticals, Inc. engages in the development of novel ribonucleic acid-modulating drug candidates. The firm focuses on the the formulation of medicines to treat rare and ultra-rare premature stop codon diseases.
CEO
Sumit Aggarwal
Employees
25
Headquarters
Waltham, Massachusetts
Founded
2017
Market Cap
117.89M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
99.72K
High Today
$3.20
Low Today
$2.92
Open Price
$3.20
Volume
86.81K
52 Week High
$6.77
52 Week Low
$1.94
ELOX Earnings
-$0.39
-$0.26
-$0.13
$0.00
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Estimated
— per share
Actual
Expected May 6, After Hours